Post Marketing Information DHCPL 18/03/2024 Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine
ORAL Select a brand starting with the letter: M P MENDICOF SYRUP (REVISED FORMULA) [SIN11516P] PAEDICOF SYRUP (REVISED FORMULA) [SIN11515P]